Condition
Endocrine Neoplasia
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting1
Unknown1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05335811Phase 1RecruitingPrimary
First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging
NCT05446779Active Not Recruiting
Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death
NCT03973450Unknown
Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia
Showing all 3 trials